Epigral · NSE: EPIGRAL · BSE: 543332
Q2 FY23 results · Jul–Sep 2022
Epigral reported revenue from operations of ₹555.53 crore (up 63.6% from Q2 FY22) and net profit of ₹91.57 crore (up 94.8% from Q2 FY22) for Q2 FY23 (Jul–Sep 2022), on a consolidated basis.
| Item | Q2 FY23 | Q2 FY22 | YoY | Q1 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 555.53 | 339.63 | +63.6% | 532.85 | +4.3% |
| Other income | 1.68 | 2.26 | −25.9% | 2.03 | −17.4% |
| Total income | 557.21 | 341.89 | +63.0% | 534.88 | +4.2% |
| Profit before tax | 141.66 | 71.34 | +98.6% | 156.33 | −9.4% |
| Net profit for the period | 91.57 | 47.01 | +94.8% | 107.79 | −15.1% |
| EPS, basic (₹) | 22.04 | 11.31 | +94.9% | 25.94 | −15.0% |
| Net margin (%) | 16.5 | 13.8 | 20.2 |
| Item | Q2 FY23 | Q2 FY22 | YoY | Q1 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 555.53 | 339.63 | +63.6% | 532.85 | +4.3% |
| Other income | 1.68 | 2.26 | −25.9% | 2.03 | −17.4% |
| Total income | 557.21 | 341.89 | +63.0% | 534.88 | +4.2% |
| Profit before tax | 141.66 | 71.34 | +98.6% | 156.33 | −9.4% |
| Net profit for the period | 91.57 | 47.01 | +94.8% | 107.79 | −15.1% |
| EPS, basic (₹) | 22.04 | 11.31 | +94.9% | 25.94 | −15.0% |
| Net margin (%) | 16.5 | 13.8 | 20.2 |
Consolidated
- Filed with BSE
- 20 Oct 2022, 16:20 IST
- Board meeting
- 20 Oct 2022
- Period
- 01 Jul 2022 to 30 Sep 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 20 Oct 2022, 16:20 IST
- Board meeting
- 20 Oct 2022
- Period
- 01 Jul 2022 to 30 Sep 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE